Ultralife Corporation
NASDAQ:ULBIElectrical Equipment & Parts
+$0.08 today
- Market cap
- $261.13M
- Beta
- 0.76
- P/E (TTM)
- -12.9
- EPS (TTM)
- -$0.49
Volume 0.10M
Average 0.05M
ULBI Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Ultralife CorporationNASDAQ: ULBI
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents broadly unchanged from a year ago
Cash & equivalents stood at $8.89M at the end of Q1 FY2026, up 2.0% from a year earlier and down 4.9% from the prior quarter. Over 3 fiscal years it compounded at +17.8% a year.
Context
- Cash & equivalents amounted to 4.0% of total assets at the end of Q1 FY2026, up 0.1 pp from a year earlier.
- Cash & equivalents increased in 2 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +2.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 9.35M USD
- Year-over-year change
- +36.3%
- 4-year CAGR
- +2.7%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 9.35M | +36.3% |
| FY2024 | 2024-12-31 | 6.85M | -33.3% |
| FY2023 | 2023-12-31 | 10.28M | +79.9% |
| FY2022 | 2022-12-31 | 5.71M | -32.1% |
| FY2021 | 2021-12-31 | 8.41M | — |
Cash & Equivalents vs competitors
How ULBI compares with its peers on the latest reported figures
- ULBI's Mar 2026 cash & equivalents of $8.89M is the 4th highest of the 7 companies compared; the peer median is $8.2M.
- Its year-over-year change of +2.0% is the 4th highest of 7, against a peer median of +11.5%.
- Cash & equivalents amounts to 4.0% of total assets for ULBI, versus a peer median of 9.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $21.16M | +52.7% | +32.5% | 22.0% | |
| Mar 2026 | $14.8M | +1522.6% | +112.4% | 88.4% | |
| Mar 2026 | $9.34M | +130.5% | +8.4% | 1.9% | |
| Mar 2026 | $8.89M | +2.0% | +17.8% | 4.0% | |
| Jan 2026 | $7.06M | -29.6% | -5.2% | 17.2% | |
| Mar 2026 | $3.94M | -43.1% | -16.4% | 0.8% | |
| Mar 2026 | $1.01M | -51.4% | +8.5% | 1.1% | |
| Peer median (excluding ULBI) | $8.2M | +11.5% | +8.4% | 9.5% | |
Competitors are the stored peer set for ULBI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 8.41M | 5.71M | 10.28M | 6.85M | 9.35M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 20.23M | 27.78M | 31.76M | 29.37M | 33.95M |
| Inventory | 33.19M | 41.19M | 42.22M | 51.36M | 54.01M |
| Other Current Assets | 4.69M | 4.3M | 0 | 0 | 8.5M |
| Total Current Assets | 66.52M | 78.99M | 90.2M | 97.16M | 105.8M |
| Property, Plant & Equipment (Net) | 25.79M | 23.9M | 24.71M | 40.49M | 40.4M |
| Goodwill | 38.07M | 37.43M | 37.57M | 45.01M | 45.38M |
| Intangible Assets | 17.39M | 15.92M | 15.11M | 24.56M | 10.93M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 11.47M | 12.07M | 10.57M | 8.41M | 10.49M |
| Other Non-current Assets | 298K | 121K | 122K | 4.83M | 3.91M |
| Total Non-current Assets | 93.01M | 89.44M | 88.07M | 123.29M | 111.11M |
| Total Assets | 159.54M | 168.43M | 178.28M | 220.45M | 216.91M |
| Account Payables | 9.82M | 16.07M | 11.34M | 14.16M | 17.42M |
| Short-term Debt | 2.87M | 2.9M | 2M | 2.75M | 4.13M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 119K | 0 | 0 | 0 |
| Other Current Liabilities | 4.39M | 6.93M | 287K | 298K | 2.75M |
| Total Current Liabilities | 18.92M | 28.91M | 23.73M | 29.29M | 37.33M |
| Long-term Debt | 18.86M | 19.31M | 23.62M | 51.5M | 45.53M |
| Deferred Tax Liabilities | 2.25M | 1.92M | 1.71M | 1.44M | 1M |
| Deferred Revenue (Non-current) | 0 | 563K | 0 | 0 | 0 |
| Other Non-current Liabilities | 17K | 17K | 1.14M | 1.03M | 2.92M |
| Total Non-current Liabilities | 22.87M | 23.11M | 29.12M | 56.97M | 49.45M |
| Total Liabilities | 41.8M | 52.03M | 52.85M | 86.26M | 86.78M |
| Common Stock | 2.05M | 2.06M | 2.08M | 2.11M | 2.11M |
| Retained Earnings | (47.83M) | (47.95M) | (40.75M) | (34.44M) | (40.34M) |
| Accumulated OCI | (1.65M) | (3.75M) | (3.66M) | (4.01M) | (3.14M) |
| Other Stockholders Equity | 0 | 0 | 0 | (1) | 0 |
| Minority Interest | 127K | 126K | 95K | 192K | 139K |
| Total Equity | 117.74M | 116.4M | 125.43M | 134.19M | 130.13M |
| Total Debt | 23.47M | 23.51M | 29.16M | 58.39M | 49.65M |
| Net Debt | 15.05M | 17.8M | 18.88M | 51.53M | 40.31M |
Ultralife Corporation
NASDAQ:ULBI
Intrinsic Alpha fair value
Locked
Current Price
$15.67
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.